Our understanding of the mechanisms whereby BACE1, the aspartyl protease required for the initial cleavage of APP to generate amyloid-b (Ab), is regulated in Alzheimer's disease (AD) remains incomplete. In this issue of Neuron, O'Connor and coworkers show how energy deprivation, a potential risk factor in AD, triggers the phosphorylation of the translation initiation factor eIF2a to elevate the translation efficiency of a set of stress-related transcripts, including that of BACE1, and increases the level of BACE1, thereby accelerating amyloidogenesis.
b-site APP cleaving enzyme 1 (BACE1) is the rate-limiting enzyme that makes the initial cleavage of the amyloid-b precursor protein (APP) and, in concert with g-secretase, gives rise to neurotoxic b-amyloid peptides (Ab). Ab accumulates in brains of individuals with Alzheimer's disease (AD), and it is believed that Ab plays a central pathogenic role in this devastating illness of the elderly. The observations that levels and activity of BACE1 are increased in brains of cases of AD (Yang et al., 2003) led to the idea that chronic increase of BACE1 in the brain may contribute to the development of AD. Over the past several years, concerted efforts have focused attention on the identification and characterization of molecular mechanisms that may upregulate the levels of BACE1 in AD. Altered energy metabolism in the brain has been considered as a risk factor for AD (de Leon et al., 2007) . Moreover, the finding that energy metabolism inhibition elevated the levels of BACE1 and Ab posttranscriptionally strongly supports the view that energy deprivation could enhance amyloidogenesis in AD (Velliquette et al., 2005) .
In this issue of Neuron, O'Connor and researchers report on a protein translation mechanism that controls the levels of BACE1 in the context of energy deprivation that may have direct relevance to the pathogenesis of AD. To begin to address how BACE1 is regulated in response to energy inhibition, O'Connor and coworkers employed an in vitro model of energy deficiency. Consistent with their previous work (Velliquette et al., 2005) , these workers showed first that, using BACE1-expressing cells challenged with glucose deprivation, the observed increase of BACE1 was determined to be consistent with a posttranscriptional mechanism. Because it is known that BACE1 protein stability can be influenced by the lysosomal and ubiquitin-proteasomal degradation pathways (Tesco et al., 2007) , O'Connor and colleagues assessed whether protein stability might be responsible for the BACE1 upregulation in response to glucose deprivation; however, pulse-chase studies revealed that this was not the case. So, what posttranscription mechanism might be involved? One clue came from earlier studies documenting that translation is inhibited by the BACE1 mRNA 5 0 UTR (Lammich et al., 2004; Rogers et al., 2004) which shares features typical of translationally regulated stress-responsive mRNAs. To test the idea that the BACE1 transcript might be a target of translational control by glucose deprivation, these investigators examined whether the 5 0 UTR of BACE1 transcript was required for the energy-deprivationdependent increase of BACE1. Interestingly, results from their mutagenesis studies showed that the BACE1 mRNA 5 0 UTR is indeed necessary. Taken together, these results strongly support the view that a translation control mechanism is responsible for the energy-deprivation-dependent increase of BACE1.
To gain insight into this protein translation mechanism, these researchers assessed whether levels of BACE1 could be regulated by specific phosphoproteins that are central to stress-induced translational control pathways given that the BACE1 mRNA is a member of the family of translationally regulated stress-response transcripts. Intriguingly, in their initial screen, they identified the a subunit of eukaryotic translation initiation factor 2 (eIF2a), which is highly phosphorylated at Ser51 in response to glucose deprivation and found that selective inhibition of eIF2a dephosphorylation increases BACE1 level even in the absence of glucose deprivation. These results indicate that eIF2a is a key component of the translation initiation complex involved in the energy-deprivation-activated BACE1 elevation and that BACE1 is a translational target of the stress-induced eIF2a-P (Ser51) pathway. To further substantiate the important role of eIF2a in BACE1 translational control, O'Connor and colleagues showed that the inhibition of eIF2a phosphorylation completely prevents the energy-deprivation-induced BACE1 increase.
To uncover the kinase(s) directly responsible for the phosphorylation of eIF2a, these researchers screened for the four known kinases, including PERK and GCN2, which are respectively activated by the ER stress and amino acid deprivation. Importantly, they were able to identify PERK as the specific kinase that phosphorylates eIF2a during glucose deprivation that governs the translational efficiency of BACE1 mRNAs. Importantly, these workers confirmed that such translational control of BACE1 in response to energy deprivation also occur in primary neuronal cultures.
But a critical question relevant to AD is whether this enhanced translational efficiency of BACE1 mRNA impacts on amyloidogenesis. To address this, O'Connor and colleagues took two approaches. First, they derived neuronal cultures from a mouse model of amyloidosis (Tg2576 mice) and showed that selective inhibition of eIF2a dephosphorylation of these neurons elevated levels of BACE1, as expected, but importantly led to increased secretion of Ab. In a second, in vivo approach, these investigators took advantage of their previously characterized energy-deprivation models (namely, 2-deoxyglucose, a competitive inhibitor of hexokinase; and 3-nitropropionic acid, an inhibitor of the Krebs cycle and succinate dehydrogenase) to treat Tg2576 mice with inhibitors of energy metabolism that resulted in elevation of BACE1 and Ab (Velliquette et al., 2005) . Here, they showed that chronic energy inhibition in Tg2576 mice over a period of 3 months enhanced the phosphorylation of eIF2a and elevated levels of BACE1 as expected and, importantly, increased the amyloid burden in this mouse model. Thus, these results provide strong support for the view that chronic energy deprivation in vivo enhances amyloidogenesis through a protein translation mechanism involving phosphorylation of eIF2a that influenced the translational efficiency of BACE1 mRNA.
Finally, to address the disease relevance of their findings, O'Connor et al. asked whether there is a correlation between eIF2a phosphorylation with the increase of BACE1 in a mouse model of amyloidosis and in AD. They first examined levels of BACE1 and eIF2a in brains of mice that exhibit extensive amyloid burden (5XFAD mice; Oakley et al., 2006) . Consistent with their recent findings (Zhao et al., 2007) , they observed that BACE1 levels in 5XFAD brains were significantly increased. Importantly, levels of phosphorylated eIF2a (Ser51) were also increased in brains of 5XFAD mice. In examining brains from a cohort of individuals with AD, these investigators found that BACE1 levels were significantly increased in brains of AD cases as previously reported; moreover, phosphorylation of eIF2a (Ser51) was concordantly elevated in brains of these individuals with AD. Together, these results favor the notion that inappropriate phosphorylation of eIF2a may contribute to the pathogenesis of AD by increasing the translation efficiency of BACE1 transcripts.
This novel work of O'Connor et al. addresses the important question as to how BACE1 can be upregulated through translational control via phosphorylation of eIF2a under a specific pathophysiological context and offers a plausible molecular explanation for the upregulation of BACE1 observed in cases of AD, a proportion of which may be linked to the energy deprivation associated with this illness. Importantly, these efforts highlight the emerging view that the levels of BACE1 can be elevated through multiple ways in AD and indicate that the molecular mechanisms that govern such upregulation of BACE1 may be context dependent. This notion raises the possibility that a variety of risk factors associated with AD could converge upon BACE1 and impact on different pathways that influence the transcriptional, posttranscriptional, translational, or posttranslational upregulation of BACE1. Whereas energy deprivation triggers the phosphorylation of eIF2a to increase the translation efficiency of BACE1 mRNA, other mechanisms that upregulate BACE1 levels may occur under distinct pathophysiological context. For example, BACE1 levels can be elevated in cases of AD through the stabilization of cyclin-dependent kinase-5 by increased levels of p25 that activate specific transcription regulators to alter the rate of BACE1 transcription (Wen et al., 2008) . Alternatively, during apoptosis, caspase-3 cleavage of the adaptor protein GGA3 required for lysosomal degradation of BACE1 could stabilize BACE1 to increase Ab generation in AD (Tesco et al., 2007) . Interestingly, noncoding antisense RNA to BACE1 that is capable of increasing levels of BACE1 and consequently levels of Ab through stabilization of BACE1 mRNA, are elevated in cases of AD (Faghihi et al., 2008) . Finally, altered regulation of microRNAs Hé bert et al., 2008) has been shown to correlate with upregulation of BACE1 in AD.
The extent to which these BACE1 regulatory mechanisms, including that described by O'Connor and coworkers, contribute to sporadic AD remains to be clarified. It will be interesting to determine in the future whether phosphorylation of eIF2a is triggered during early stages of AD or in individuals exhibiting mild cognitive impairment. Additional efforts will be required to clarify the mechanism whereby eIF2a phosphorylation controls the derepression of BACE1 mRNA translation in the future. Their work also raised the intriguing possibility of additional stressrelated targets that are regulated by phosphorylation of eIF2a and whether they too may contribute to the pathogenesis of AD. It will be important in future work to determine whether translation repression of BACE1 mRNA could be relieved under various stressful conditions associated with AD. Nevertheless, if it is true that the upregulation of BACE1 triggered by different mechanisms related to various pathophysiological contexts occurs as an early step in the pathogenesis of AD, the work of O'Connor and coworkers would further emphasize the importance of targeting BACE1 as an anti-amyloid therapy in efforts to attenuate amyloidogenesis in AD. The recent discovery that BACE1 also influences neuregulin processing and neuregulin-ErbB signaling in the nervous system (Willem et al., 2006; Hu et al., 2006; Savonenko et al., 2008) raised the plausibility that pharmacological inhibition of BACE1 may not be completely free of mechanism-based toxicity, and future clinical trials should be alert to potential untoward side effects associated with this type of anti-amyloid therapy for AD.
Drosophila melanogaster has a broad geographic range. Daily activity in this species exhibits seasonality such that midday rest expands on long warm days, possibly to avoid desiccation. Comparative analyses show that temperature-dependent control of this behavior is partly linked to patterns of per mRNA splicing that are absent in Drosophila yakuba, a related species native to warmer climates with little seasonal change.
Life as we know it on Earth exists between approximately À15
C and 120 C, a narrow sliver of the range of temperatures found throughout the universe. Because of the strong temperature sensitivity of most biochemical reactions, it comes as no surprise that even small temperature variations within these limits, such as those associated with gradual climate change, have profound effects on living organisms. It is also easy to see the adaptive significance of evolved mechanisms that allow organisms to anticipate changes in environmental temperature and adjust to them. Many animals exhibit differential activity patterns in warmer versus colder seasons, hibernation being an extreme example. Seasonal timekeeping mechanisms that govern these behaviors often make use of day length as a reliable indicator of the time of year. In this context, day length is commonly measured by the coincidence of light and certain phases of the internal daily time keeping mechanisms of the circadian clock (Dunlap et al., 2004) .
A little less than a decade ago Majercak and colleagues reported in these pages a molecular mechanism underlying seasonal adaptive behavior in the fruit fly Drosophila melanogaster (Majercak et al., 1999) . Cold temperatures induced flies to show earlier evening-associated locomotor activity and a decreased period of midday rest. This mechanism is proposed to be seasonally adaptive because it allows flies to avoid midday activity during hot spring and summer days when there may be a risk of desiccation, while allowing midday activity during colder fall and winter days when it may be advantageous. Temperature-dependent mRNA splicing of dmpi8 the terminal intron in the circadian clock gene period (per) was shown to make a substantial contribution to this response by affecting the phase of accumulation of both per transcript and PER protein. The fact that per forms the entry point for seasonal modulation of circadian timing is consistent with its central role in the circadian clock circuits. In the Drosophila circadian clock, per is one of the transcriptional targets for CLOCK/ CYCLE (CLK/CYC), a heterodimeric complex of two bHLH (basic helix-loophelix) PAS (PER-ARNT-SIM) transcription factors that activates expression at dusk. PER protein accumulates with a substantial delay relative to per transcript, in part because it is destabilized by phosphorylation events that promote its degradation through the ubiquitin-proteosome pathway. The accumulation of TIMELESS (TIM) protein, the product of another CLK/ CYC regulated gene, is necessary to stabilize PER in a complex that also includes the kinase DOUBLETIME (DBT) and to mediate nuclear transfer around midnight. TIM itself is subject to lightdependent degradation, allowing the clock circuits to be synchronized to environmental light/dark signals. Once in the nucleus, PER directly interacts with CLK/ CYC and inhibits promoter binding, thus, providing negative feedback on the transcription of per, tim, and other coregulated genes (see Figure 1 ; Dubruille and Emery, 2008; Hardin, 2005; Stanewsky, 2003; Wijnen and Young, 2006) .
The status of per as a dosage-dependent regulator of circadian time keeping was established in early studies examining the relationship between per gene dosage and period length. Mutant alleles
